Effectdossier · gearchiveerd kwartaal
NUVB
Nuvation Bio Inc. · Healthcare · Biotechnology
15Gevolgde houders
0Δ houders
120.03MGehouden aandelen
$233.06MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +7.8% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 97 | +2 | 157.38M | $893.56M | +5 | −3 |
| Q1 2026 | 98 | +3 | 147.71M | $634.66M | +12 | −9 |
| Q4 2025 | 94 | +2 | 141.34M | $1.26B | +2 | — |
| Q3 2025 | 19 | +1 | 120.52M | $443.85M | +2 | −1 |
| Q2 2025 | 15 | 0 | 120.03M | $233.06M | +1 | −1 |
| Q1 2025 | 12 | -1 | 18.55M | $32.01M | — | −1 |
| Q4 2024 | 13 | 0 | 18.40M | $47.86M | — | — |
| Q3 2024 | 12 | +1 | 12.76M | $28.26M | +1 | — |
| Q2 2024 | 11 | — | 9.41M | $26.24M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 51.04M | — | $99.53M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 51.04M | — | $99.53M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 51.04M | — | $99.53M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 51.04M | — | $99.53M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 25.89M | — | $50.22M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (passief) | 15.90M | — | $31.01M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (passief) | 15.90M | — | $31.01M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | The Vanguard Group ✦ (passief) | 15.90M | — | $31.01M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | The Vanguard Group ✦ (passief) | 15.90M | — | $31.01M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 15.90M | — | $31.01M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Geode Capital Management ✦ (passief) | 5.99M | +16.8% | $11.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Geode Capital Management ✦ (passief) | 5.99M | +16.8% | $11.69M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (passief) | 5.56M | +14.5% | $10.84M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 5.61M | +157.2% | $10.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 5.61M | +157.2% | $10.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Citadel Advisors ✦ | 5.61M | +157.2% | $10.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 5.61M | +157.2% | $10.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Millennium Management ✦ | 5.38M | +42.6% | $10.49M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Two Sigma Investments ✦ | 1.21M | +76.7% | $2.37M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 1.14M | +739.9% | $2.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 1.14M | +739.9% | $2.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 1.14M | +739.9% | $2.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 1.14M | +739.9% | $2.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Marshall Wace ✦ | 871.19K | Nieuw | $1.70M | 0.0% | New | 1 | SEC ↗ |
| 40 | Marshall Wace ✦ | 871.19K | Nieuw | $1.70M | 0.0% | New | 1 | SEC ↗ |
| 41 | Wellington Management ✦ | 733.54K | +5.9% | $1.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 42 | Wellington Management ✦ | 733.54K | +5.9% | $1.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 733.54K | +5.9% | $1.43M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 277.32K | +19.6% | $541,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Greenlight Capital (DME Capital) ✦ | 135.00K | 0.0% | $95,230 | 0.0% | Held | 5 | SEC ↗ |
| 46 | Greenlight Capital (DME Capital) ✦ | 135.00K | 0.0% | $95,230 | 0.0% | Held | 5 | SEC ↗ |
| 47 | Adage Capital Partners ✦ | 266.67K | 0.0% | $71,973 | 0.0% | Held | 5 | SEC ↗ |
| 48 | Renaissance Technologies ✦ | 22.10K | -95.0% | $43,095 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $1.70M | 0.0% |
| Marshall Wace | $1.70M | 0.0% |
Verlaten
| D. E. Shaw & Co. | $21,296 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 230 houders, 219.97M aandelen, $906.24M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Aug 19
Hattersley Gary
Officer · 100.00K aand · $709,240
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API